Market Cap 1.38B
Revenue (ttm) 731.97M
Net Income (ttm) 159.52M
EPS (ttm) N/A
PE Ratio 8.17
Forward PE 9.88
Profit Margin 21.79%
Debt to Equity Ratio 0.82
Volume 353,570
Avg Vol 565,782
Day's Range N/A - N/A
Shares Out 47.65M
Stochastic %K 91%
Beta 0.77
Analysts Sell
Price Target $38.20

Latest News on AMPH

Top 2 Health Care Stocks That May Rocket Higher This Month

Feb 21, 2025, 2:17 PM EST - 5 weeks ago

Top 2 Health Care Stocks That May Rocket Higher This Month

WST


Amphastar Pharmaceuticals: A Gradual Strategy

Feb 19, 2025, 1:09 PM EST - 5 weeks ago

Amphastar Pharmaceuticals: A Gradual Strategy


Amphastar Pharmaceuticals: Cheap With Caveats

Jan 3, 2025, 12:48 PM EST - 3 months ago

Amphastar Pharmaceuticals: Cheap With Caveats


Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 6 months ago

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2


6 Beaten Down Stocks Rated Buy (SA Quant)

Aug 19, 2024, 5:00 AM EDT - 8 months ago

6 Beaten Down Stocks Rated Buy (SA Quant)

CAAP CCL STRL TCOM TWLO


Amphastar Pharmaceuticals: Buy When Fear Is Overblown

May 30, 2024, 2:06 AM EDT - 10 months ago

Amphastar Pharmaceuticals: Buy When Fear Is Overblown


Amphastar Pharmaceuticals: Profitable Pharma With Strong Growth

May 20, 2024, 5:29 AM EDT - 11 months ago

Amphastar Pharmaceuticals: Profitable Pharma With Strong Growth